HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >About CMDv
  • >Working Groups
  • CMDv
    • About CMDv
      • Role of CMDv
      • CMDv Composition
      • Working Groups
        • Inactive Working Groups
      • CMDv Meeting Dates
      • Planning & Reporting
      • Stakeholder Interactions
    • Implementation of the VMP Regulation
    • COVID-19
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

Working Groups

Active Substance Master File Working Party (Joint)

Borderline Products

 - Overview of regulatory framework for borderline products

Document Management

Legislation

SPC Harmonisation

Variation Regulation Working Party (Joint) 

 

Inactive Working Groups

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/about-cmdv/working-groups.html